.
. the hearings in the european parliament with the participation of the founder of facebook , mark zuckerberg, will pass in the closed mode..
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
share on twitter twitter .